Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	10061
Country	United States

Received	2014-03-11 10:50
Peer-Review Started	2014-03-11 19:10
To Make the First Decision	2014-04-15 15:12
Return for Revision	2014-04-18 10:55
Revised	2014-05-20 22:10
Second Decision	2014-06-11 14:07
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-11 14:27
Articles in Press	2014-06-11 15:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-19 14:26
Publish the Manuscript Online	2014-09-20 20:21

ISSN	2218-6220 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Clinical Trials Study
Article Title	Utility of a hemoglobin A1C obtained at the first prenatal visit
Manuscript Source	Invited Manuscript
All Author List	Lisa E Moore and Diana Clokey
Funding Agency and Grant Number
Corresponding Author	Lisa E Moore, MD, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of New Mexico, MSC105580, Albuquerque, NM 87131, United States. lemoore@salud.unm.edu
Key Words	Gestational diabetes; Pregnancy; Hemoglobin A1C; Glycosylated hemoglobin
Core Tip	Hemoglobin A1C (HbA1C) has been endorsed by the World Health Organization for use in diagnosing diabetes and also for identifying degrees of glucose intolerance. This has not been validated in pregnancy. This study looks at a cohort of patients who received a HbA1C at the begining of pregnancy to see if the HbA1C can be used as a triaging tool for identifying patients with undiagnosed diabetes and for identifying a degree of glucose intolerance that would benefit from early intervention. HbA1C ≥ 6.5% is consistent with preexisting diabetes. HbA1C between 5.7% and 6.4% demonstrates a level of glucose intolerance associated with risk of Gestational Diabetes which may benefit from early intervention.
Publish Date	2014-09-20 20:21
Citation	Moore LE, Clokey D. Utility of a hemoglobin A1C obtained at the first prenatal visit. World J Obstet Gynecol 2014; 3(3): 130-133
URL	http://www.wjgnet.com/2218-6220/full/v3/i3/130.htm
DOI	http://dx.doi.org/10.5317/wjog.v3.i3.130

Full Article (PDF)	WJOG-3-130.pdf
Full Article (Word)	WJOG-3-130.doc
Manuscript File	10061-Review.docx
Answering Reviewers	10061-Answering reviewers.pdf
Biostatistics Review Certificate	Biostatistician_Review_Report_20140311063643.docx
Copyright License Agreement	10061-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	Ethics_Committee_20140311063517.pdf
Peer-review Report	10061-Peer review(s).pdf
Scientific Misconduct Check	10061-CrossCheck.jpg
Scientific Editor Work List	10061-Scientific editor work list.pdf